Department of Radiology, Perelman School of Medicine at the University of Pennsylvania, 3400 Spruce St., Philadelphia, PA, 19104, USA.
Department of Radiodiagnosis, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raebareily Road, Lucknow, Uttar Pradesh, 226014, India.
World J Urol. 2019 Oct;37(10):2175-2182. doi: 10.1007/s00345-018-2604-0. Epub 2018 Dec 17.
To evaluate the efficacy and outcome of superselective vesical arterial embolization in the management of severe intractable hematuria secondary to hemorrhagic cystitis.
We retrospectively reviewed the medical records of nine patients with severe intractable hematuria treated with superselective vesical artery embolization at our institution between March 2003 and February 2015. There were six males and three females with a mean age of 56.1 years. Seven patients had transitional cell carcinoma (TCC) of urinary bladder and had undergone transurethral resection of bladder tumor and pelvic radiotherapy. One patient had synchronous renal pelvis and bladder TCC. One patient had aortoarteritis and was receiving cyclophosphamide therapy and another patient had carcinoma cervix post-pelvic radiotherapy. Following the failure of conservative management, superselective vesical artery catheterization and embolization was performed with 300-500-μ PVA particles in all patients. Coil embolization of inferior gluteal artery followed by particle embolization of vesical arteries was done in one patient in whom superior, inferior vesical and inferior gluteal arteries were arising as a trifurcation.
The technical success rate was 100% with complete cessation of hematuria within 48 h in all patients. No significant complications were noted, except for post-embolization syndrome in one patient, which improved on symptomatic treatment. During a mean follow-up period of 14.45 months (ranging from 3-28 months), one patient had mild recurrent hematuria (at 2 months) which resolved spontaneously.
Superselective vesical artery embolization is a safe and effective procedure in controlling intractable life-threatening hematuria in a select group of patients who have failed conventional treatment protocols. This procedure may be considered as the treatment of choice since it usually obviates the need for emergency surgery in these severely ill patients.
评估超选择性膀胱动脉栓塞术在治疗出血性膀胱炎引起的严重难治性血尿中的疗效和结果。
我们回顾性分析了 2003 年 3 月至 2015 年 2 月期间我院 9 例严重难治性血尿患者接受超选择性膀胱动脉栓塞治疗的病历。其中男性 6 例,女性 3 例,平均年龄 56.1 岁。7 例患者为膀胱癌,行经尿道膀胱肿瘤切除术和盆腔放疗。1 例患者同时患有肾盂膀胱癌。1 例患者患有巨细胞动脉炎,正在接受环磷酰胺治疗,另 1 例患者患有宫颈癌盆腔放疗后。在保守治疗失败后,所有患者均行超选择性膀胱动脉导管插入术和栓塞术,使用 300-500-μ PVA 颗粒。1 例患者因膀胱上、下动脉和臀下动脉呈三分叉,先行臀下动脉线圈栓塞,再行膀胱动脉颗粒栓塞。
所有患者的技术成功率均为 100%,48 小时内完全停止血尿。除 1 例患者出现栓塞后综合征,经对症治疗后改善外,无明显并发症。平均随访 14.45 个月(3-28 个月),1 例患者 2 个月时有轻度复发性血尿,自行缓解。
超选择性膀胱动脉栓塞术是一种安全有效的方法,可控制经常规治疗方案失败的特定患者群体中危及生命的难治性血尿。由于该方法通常可避免这些重病患者紧急手术,因此可作为首选治疗方法。